- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03339739
Effects of Mandibular Exercises Effect on Pain Perception and Sensitivity in Mandibular Myofascial Pain
Effects of Mandibular Exercises Effect in Pain Perception and Sensitivity in Women With Myofascial Pain, a Double Blind Randomized Clinical Trial.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Temporomandibular disorders (TMDs) represent heterogeneous musculoskeletal disorders, where most common presentation is mandibular muscle pain, which is also more common among female than men. Many interventions have been proposed for this pain control, regarding drugs, oral splints, relaxing exercises and self awareness but little is known about mandibular active contraction exercises. The aim of this study is to evaluate the effects of mandibular exercises in pain perception and sensitivity in women. A double blind randomized clinical trial will be conducted among fertile university student women with Oral Contraceptives (OC) use -to control hormonal influences-, with report of facial pain and myofascial pain diagnosis (RDC/TMD). They will be assessed in Visual analogue scale (VAS), sleep quality, Pressure Pain Threshold (PPT) and pressure pain tolerance (PPTol), and then allocated in one of the three interventions for 21 days: isometric mandibular active exercises over silicone bars; video-guided isotonic mandibular contractions over cloth pegs or counseling about disorders nature as passive comparison. After 21 days, VAS, PPT and PPTol in bilateral temporalis and masseter muscles will be assessed for a second time,) and compared with initial pain status.
Data will be entered by single blind operator, and will be open for quality auditing. Site monitoring will be performed by the University clinical entities.
Data checks will be also performed as planned. Descriptive and analytical statistics will be performed to address the primary and secondary objectives.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Temporomandibular Myofascial pain diagnosis
- Oral contraceptives consumption
- Facial pain for at least 3 months (and at least 10 of the last 30 days at Visit 0)
- Agrees to terms for continuing/discontinuing certain prescription/over-the-counter pain medications.
Exclusion Criteria:
- Other orofacial pain diagnosis
- Oral surgery within 6 months
- Treatment for pain management within past 30 days
- Neurological or psychiatric disorders
- Orthodontic treatment
- History of pregnancy, pregnancy or breastfeeding.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verdrievoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Isometric exercise Group
Group of participants which perform Isometric mandibular exercises, once a day, for 21 days
|
daily video guided three-minutes routine in 21 days (days of OC consumption) of soft clenching over three millimeters silicone bars bilaterally on molars
|
|
Actieve vergelijker: Isotonic exercise Group
Group of participants which perform Isotonic mandibular exercises, once a day, for 21 days
|
daily video guided three-minutes routine in 21 days (days of OC consumption) of isotonic dynamic contraction over calibrated cloth pegs on central incisors
|
|
Placebo-vergelijker: Counseling Group
Group of participants which receive education brochure and no further interventions.
|
subjects included in this group get an education brochure about the disorder and receive no further interventions
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in the weekly mean subjective pain index after 21 days of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
Weekly mean subjective pain computed as the arithmetic mean of daily pain subjective values (visual analog scale - VAS) in Visit 1and prior to each study visit.
Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = "no pain" and 100 = "the most intense pain imaginable") for the different muscular sites tested.
|
Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
|
Change in the weekly mean pressure pain threshold (PPT) after 21 days of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
Weekly mean pressure pain threshold is computed as the arithmetic mean of daily pressure pain threshold values for muscular sites in Visit 1and prior to each study visit.
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
|
Change in the weekly mean pressure pain tolerance (PPTol) after 21 days of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
Weekly mean pressure pain tolerance is computed as the arithmetic mean of daily pressure pain tolerance values for muscular sites in Visit 1and prior to each study visit.
Plot is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied per anatomical muscle site.
|
Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in pressure pain threshold at temporalis muscle after 1 week of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
|
Change in pressure pain threshold at temporalis muscle after 2 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 14) ( 7 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 14) ( 7 days in between)
|
|
Change in pressure pain threshold at temporalis muscle after 3 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 21) ( 7 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 21) ( 7 days in between)
|
|
Change in pressure pain threshold at masseter muscle after 1 week of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
|
Change in pressure pain threshold at masseter muscle after 2 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
|
Change in pressure pain threshold at masseter muscle after 3 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of t masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.
|
Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
|
Change in pressure pain tolerance at temporalis muscle after 1 week of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
|
Change in pressure pain tolerance at temporalis muscle after 2 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
|
Change in pressure pain tolerance at temporalis muscle after 3 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
|
Change in pressure pain tolerance at masseter muscle after 1 week of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
|
|
Change in pressure pain tolerance at masseter muscle after 2 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
|
|
Change in pressure pain tolerance at masseter muscle after 3 weeks of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.
|
Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
|
|
Change in the Pittsburgh Sleep Quality Index (PSQI) global score after 21 days of treatment
Tijdsspanne: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
The PSQI has 19 items grouped into 7 component scores, each weighted equally on a 0-3 scale.
The 7 component scores are summed to obtain a global score, which has a range of 0-21.
|
Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Juan F Oyarzo, Prof, Universidad Andrés Bello
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PROPRGFO_2013/004
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Temporomandibulaire aandoeningen
-
University of HoustonOnbekend
-
UCB Biopharma SRLNog niet aan het wervenOntwikkelings- en epileptische encefalopathieën | SLC6A1 Neurodevelopmental Disorder (NDD)
-
New York City Health and Hospitals CorporationBeëindigdGlaucoom | Ziekte van het netvlies | Visuele Pathway DisorderVerenigde Staten
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAanmelden op uitnodigingMacula ziekte | Visuele Pathway Disorder | Ziekte van de oogzenuwVerenigde Staten
-
Otsuka Pharmaceutical Co., Ltd.WervingAttention-deficit Hyperactivity Disorder (ADHD)Japan
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenMajor Depressive Disorder (MDD) met slapeloosheidFrankrijk
-
Otsuka Pharmaceutical Co., Ltd.WervingAttention-deficit Hyperactivity Disorder (ADHD)Japan
-
Fondazione G.B. Bietti, IRCCSVoltooidGlaucoom | Optische neuropathie, ischemische | Optische zenuw | Visuele Pathway Disorder | Neurale geleidingItalië
-
University of MiamiNational Eye Institute (NEI)VoltooidGlaucoom | Maculaire degeneratie | Retinale degeneratie | Optische neuropathie | DrDeramus verdachte | Visuele Pathway DisorderVerenigde Staten
-
Isfahan University of Medical SciencesVoltooidZiekte van Tanger | Body Mass Index Quantitative Trait Locus 5 DisorderIran, Islamitische Republiek
Klinische onderzoeken op Isometric mandibular exercises
-
Mansoura UniversityVoltooidObstructieve slaapapneu bij volwassenenEgypte
-
ethisch.comite@uza.beVoltooidObstructief slaapapneusyndroomBelgië
-
Academic Centre for Dentistry in AmsterdamShandong UniversityVoltooidObstructieve slaapapneu bij volwassenenChina, Nederland
-
Batman UniversityVoltooidMandibulaire retrognathieKalkoen
-
Damascus UniversityVoltooidKlasse II Divisie 1 Malocclusie | Retrognatische onderkaakSyrische Arabische Republiek
-
Washington University School of MedicineWervingObstructieve slaapapneuVerenigde Staten
-
Queen Mary University of LondonWerving
-
Obafemi Awolowo UniversityVoltooid
-
Damascus UniversityVoltooidKlasse II Divisie 1 MalocclusieSyrische Arabische Republiek